| Unique ID issued by UMIN | UMIN000058700 |
|---|---|
| Receipt number | R000067108 |
| Scientific Title | A double-blind trial examining the effect of lactic acid bacteria on N1487-7 lowering cholesterol levels: placebo-controlled, double-blind, randomized parallel comparative test |
| Date of disclosure of the study information | 2025/08/20 |
| Last modified on | 2025/08/04 15:15:56 |
A double-blind trial examining the effect of lactic acid bacteria on N1487-7 lowering cholesterol levels
A double-blind trial examining the effect of lactic acid bacteria on N1487-7 lowering cholesterol levels
A double-blind trial examining the effect of lactic acid bacteria on N1487-7 lowering cholesterol levels:
placebo-controlled, double-blind, randomized parallel comparative test
A double-blind trial examining the effect of lactic acid bacteria on N1487-7 lowering cholesterol levels:
placebo-controlled, double-blind, randomized parallel comparative test
| Japan |
Healthy individuals
| Adult |
Others
NO
To evaluate the effect on lowering cholesterol levels of ingestion of test food for 12 consecutive weeks, using placebo as a control.
Safety,Efficacy
Confirmatory
Not applicable
LDL cholesterol
HDL cholesterol
Total cholesterol
Oxidized LDL cholesterol
sd-LDL cholesterol
RLP cholesterol
non-HDL cholesterol
IL-10
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Prevention
| Food |
Intake of test food for 12 consecutive weeks
Intake of control placebo for 12 consecutive weeks
| 20 | years-old | <= |
| 64 | years-old | >= |
Male and Female
(1) Healthy males and females from 20 to 64 years old
(2) Participants with LDL cholesterol levels of 120-139 mg/dL or 140-159 mg/dL. However, less than half of the participants should have140-159 mg/dL.
(3) Participants who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
(1) Participants with a history of hypercholesterolemia, psychiatric disorders, diabetes, liver disease, kidney disease, digestive disorders, cardiac diseases, respiratory diseases, peripheral vascular disorders, or other serious diseases
(2) Participants who undergo surgery on the digestive tract
(3) Participants with abnormal liver and kidney function tests
(4) Participants with diseases currently being treated
(5) Participants who are allergic to food and drugs
(6) Participants with anemia symptoms
(7) Female participants wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female participants
(8) Participants who play intense sports and participants who are on a diet
(9) Participants with extremely irregular eating habits
(10) Participants who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period
(11) Participants who are continuously receiving treatment with pharmaceuticals (including OTC and prescription drugs)
(12) Participants who drink more than 60 g of average daily pure alcohol
(13) Participants who smoke an average of 21 or more cigarettes a day
(14) Participants who are participating in or will participate in other clinical trials at the start of this study.
(15) Other participants judged by the investigator or the investigator to be inappropriate for the examination
100
| 1st name | Naoki |
| Middle name | |
| Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal medicine
5300044
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
info@miura-cl.jp
| 1st name | Makoto |
| Middle name | |
| Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
5300044
Higashitenma building 6F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-4801-8917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
Sanwa Shurui Co.,ltd.
Profit organization
The Ethics Committee of Miura Clinic, Medical Corporation Kanonkai
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
mterashima@miura-cl.jp
NO
医療法人花音会みうらクリニック(大阪府)
| 2025 | Year | 08 | Month | 20 | Day |
Unpublished
Preinitiation
| 2025 | Year | 07 | Month | 23 | Day |
| 2025 | Year | 07 | Month | 30 | Day |
| 2025 | Year | 09 | Month | 11 | Day |
| 2025 | Year | 12 | Month | 31 | Day |
| 2025 | Year | 08 | Month | 05 | Day |
| 2025 | Year | 08 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067108